These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21987528)

  • 1. The impact of topiramate (Topamax®) therapy on the development of aggressive and/or agitated behavior.
    Farinde A
    J Pharm Pract; 2011 Dec; 24(6):568-70. PubMed ID: 21987528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects.
    Coppola G; Verrotti A; Resicato G; Ferrarelli S; Auricchio G; Operto FF; Pascotto A
    Epilepsy Behav; 2008 Feb; 12(2):253-6. PubMed ID: 17962081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate and psychiatric adverse events in patients with epilepsy.
    Mula M; Trimble MR; Lhatoo SD; Sander JW
    Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of being seizure free: topiramate and psychopathology in epilepsy.
    Mula M; Trimble MR
    Epilepsy Behav; 2003 Aug; 4(4):430-4. PubMed ID: 12899865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychosis following treatment with topiramate].
    Verhoeven WM; Boermans JA; van der Heijden FM; Tuinier S
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2093-5. PubMed ID: 12448965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incoercible topiramate-related vomiting in a patient with epilepsy and mental retardation.
    Striano S; Marano E; Striano P; Bilo L
    Neurol Sci; 2001 Jun; 22(3):283-4. PubMed ID: 11731887
    [No Abstract]   [Full Text] [Related]  

  • 10. Topiramate in patients with epilepsy and intellectual disability.
    Martin P; Schreiner A; Rettig K; Schäuble B
    Epilepsy Behav; 2009 Mar; 14(3):496-502. PubMed ID: 19162230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy.
    Jansen JF; Aldenkamp AP; Marian Majoie HJ; Reijs RP; de Krom MC; Hofman PA; Eline Kooi M; Nicolay K; Backes WH
    Epilepsy Behav; 2006 Aug; 9(1):181-5. PubMed ID: 16793345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erectile dysfunction with topiramate.
    Holtkamp M; Weissinger F; Meierkord H
    Epilepsia; 2005 Jan; 46(1):166-7. PubMed ID: 15660786
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible facial myoclonus with topiramate therapy for epilepsy.
    Kutluay E; Pakoz B; Beydoun A
    Epilepsia; 2007 Oct; 48(10):2001-2. PubMed ID: 17922777
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of aggressive and agitated behavior in psychiatric practice].
    Spirić Z; Preradović M; Samardzić R; Nedeljko B; Eror S
    Vojnosanit Pregl; 1999; 56(5):511-21. PubMed ID: 10645156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Causes and consequences of elderly's agitated and aggressive behavior].
    Leger JM; Moulias R; Vellas B; Monfort JC; Chapuy P; Robert P; Knellesen S; Gerard D
    Encephale; 2000; 26(1):32-43. PubMed ID: 10875060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychotic disorders induced by topiramate: report of two cases.
    Stella F; Caetano D; Cendes F; Guerreiro CA
    Arq Neuropsiquiatr; 2002 Jun; 60(2-A):285-7. PubMed ID: 12068361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The agitated patient, Part I: Evaluation and behavioral management.
    Tesar GE
    Hosp Community Psychiatry; 1993 Apr; 44(4):329-31. PubMed ID: 8462938
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrolithiasis on topiramate therapy.
    Takhar J; Manchanda R
    Can J Psychiatry; 2000 Jun; 45(5):491-3. PubMed ID: 10900534
    [No Abstract]   [Full Text] [Related]  

  • 20. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning.
    Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P
    Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.